Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Infographics

What over 70 women leaders, from those moving up the ladder to those at its peak, said about their identity.

Engagement Manager, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

It's time to get comfortable with being uncomfortable.

Partner, Health & Life Sciences, Oliver Wyman

Even the most fruitful innovators have seen small impact thus far. It’s time to hold the industry to a quantifiable yardstick.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman

Oliver Wyman's research findings on diversity in healthcare leadership (some of which surprised us).

Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Engagement Manager, Oliver Wyman
Principal, Oliver Wyman
Consultant

Oral health can be the key driver of patients' ER bills. Proper care for the body’s “gateway” is a compelling value proposition for consumers and the healthcare ecosystem.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

How measurement and monitoring will wake physicians up to their dangerous, unnecessary, (and unintentional) prescribing habits.

Global Head, Health Services, Oliver Wyman

Innovator-Led Innovations May Soon Come True

Healthcare leaders demand disruption, but who will spark big change first?

Chief Strategy Officer, National Business Group on Health
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Asian healthcare is undergoing major disruption, and a new healthcare environment is emerging.

Partner, Head of Health & Life Sciences, Asia Pacific, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

How did ChenMed go from a single physician practice to 60 clinics in 8 states, all while treating a small population segment?

President of New Markets and Chief Growth Officer, ChenMed
Partner, Health & Life Sciences, Oliver Wyman

An analysis of annual premiums by federal poverty level.

Practice Leader, Oliver Wyman Actuarial Consulting

Insights in your inbox

Subscribe